Your browser doesn't support javascript.
loading
What is the most appropriate regimen for untreated Waldenström macroglobulinemia?
Naohiro SEKIGUCHI; Airi HAMANO; Tomoko KITAGAWA; Kenichi ITO; Kazuhiko HIRANO; Kazuaki YAMADA.
Blood Research ; : 153-156, 2019.
Article in English | WPRIM | ID: wpr-763054
ABSTRACT
No abstract available.
Subject(s)
Fulltext
Print
XML
Search on Google
Full text: Available Index: WPRIM (Western Pacific) Main subject: Cost-Benefit Analysis / Waldenstrom Macroglobulinemia / Rituximab Language: English Journal: Blood Research Year: 2019 Type: Article

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
Search on Google
Full text: Available Index: WPRIM (Western Pacific) Main subject: Cost-Benefit Analysis / Waldenstrom Macroglobulinemia / Rituximab Language: English Journal: Blood Research Year: 2019 Type: Article